Monica Jönsson

Title: **Innovator Spotlight: Monica Jönsson**

Introduction

Monica Jönsson, an accomplished inventor based in Bara, Sweden, has made significant contributions to the field of biotechnology. With a total of five patents to her name, she has focused primarily on the development of innovative microparticle technologies that have important applications in medicine.

Latest Patents

Her latest patent pertains to a novel process for producing parenterally administrable microparticles using a 20% by weight aqueous solution of purified amylopectin-based starch of reduced molecular weight. This cutting-edge process involves combining the starch solution with biologically active substances to form an emulsion of starch droplets. These droplets are then gelled before the formation of dried starch particles. Notably, the microparticles produced have an amino acid content of less than 50 µg and are designed without covalent chemical cross-linking, enhancing their efficacy and safety for medical use.

Career Highlights

Monica currently works at Jagotec AG, a company committed to advancing pharmaceutical technologies. Her role has been instrumental in the development of biocompatible materials, further solidifying her reputation as a forward-thinking inventor in the biotechnology sector.

Collaborations

Throughout her career, Monica has collaborated with talented professionals in her field, including colleagues Timo Laakso and Mats Reslow. These partnerships have not only enriched her work but have also led to breakthroughs in the development of innovative microparticle systems.

Conclusion

Monica Jönsson's contributions to the field of biotechnology through her innovative microparticle technologies exemplify her commitment to improving medical treatments. With several patents under her belt and ongoing collaboration with esteemed colleagues, she continues to push the boundaries of scientific discovery in Sweden and beyond.